SUBSCRIBE
SUBSCRIBE

Senti Biosciences

NEWS
Business
BioSpace Movers & Shakers, Oct. 18
Pharma, biotech and medtech companies strengthen their executive ranks and boards with this week’s Movers & Shakers.
October 17, 2019
 · 
5 min read
 · 
Alex Keown
Business
Senti Biosciences Brings on Curt Herberts to Help Build New Partnerships
South San Francisco-based Senti Biosciences is getting a new Chief Financial Officer and Chief Business Officer. Former Sangamo Therapeutics Senior Vice President and Chief Business Officer Curt Herberts will join Senti later this month.
June 6, 2018
 · 
1 min read
 · 
Don McCormick
Biotech Bay
Senti Biosciences Raises $53 Million from Amgen and Others in Series A Financing
Senti Biosciences, based in South San Francisco, has completed a $53 million Series A financing.
February 27, 2018
 · 
3 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Press Releases
Senti Bio to Participate in Upcoming Investor Conferences
September 3, 2024
 · 
7 min read
Business
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights
August 13, 2024
 · 
10 min read
Press Releases
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202
August 5, 2024
 · 
8 min read
Press Releases
Senti Bio Announces Reverse Stock Split
July 16, 2024
 · 
8 min read
Drug Development
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
May 13, 2024
 · 
9 min read
Business
Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights
May 9, 2024
 · 
11 min read
Drug Development
Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)
April 30, 2024
 · 
8 min read
Business
Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
March 21, 2024
 · 
11 min read
Biotech Bay
Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
January 5, 2024
 · 
8 min read
FDA
Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
December 22, 2023
 · 
10 min read
Load More